Sinovac applies for conditional approval of COVID-19 vaccine in China

Tens of thousands have already gotten CoronaVac; Sinopharm shot also under review

WANG LIJUN, WANG ZHUOQING and DENISE JIA, Caixin

February 5, 2021 00:00 JST

China's medicine regulator is reviewing a second domestically developed COVID-19 vaccine for conditional approval.

Read Next

Beijing Winter Olympics face COVID and boycott hurdles to stay on track

Beijing Winter Olympics face COVID and boycott hurdles to stay on track

Coronavirus: Free to read

Coronavirus: Week of Jan. 31 to Feb. 6, South Korea eases curfew on businesses outside Seoul

Coronavirus: Week of Jan. 31 to Feb. 6, South Korea eases curfew on businesses outside Seoul

Global COVID-19 cases top 100m as mutations multiply

Global COVID-19 cases top 100m as mutations multiply

Threat of fresh COVID surge freezes China's annual travel rush

Threat of fresh COVID surge freezes China's annual travel rush

Chinese New Year tests COVID control as millions hit the road

Chinese New Year tests COVID control as millions hit the road

Charting COVID-19 vaccinations around the world: Infographics

Charting COVID-19 vaccinations around the world: Infographics

Latest on Caixin

Record spending on Belt and Road targets energy and mineral resources

Record spending on Belt and Road targets energy and mineral resources

Sinovac's COVID fortune fuels bitter boardroom battle

Sinovac's COVID fortune fuels bitter boardroom battle

China launches fusion energy firm with $1.6bn investment from SOEs

China launches fusion energy firm with $1.6bn investment from SOEs

Sponsored Content